Clinical Trial: Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644403) titled 'Phase I/IIa Clinical Trial of IMC001 in Patients With Advanced Epithelial Solid Tumors.' on Jan. 20.

Brief Summary: This is an open -label phase I /IIa study designed to evaluate the safety and efficacy of IMC001 in patients with advanced epithelial solid tumors. The study comprises two parts: a phase I dose-escalation phase and a phase IIa phase to further explore and validate efficacy .In the Phase I dose-escalation phase of this study, approximately 7-15 subjects with advanced epithelial solid tumors will be recruited to evaluate the safety and tolerability of autologous IMC001 treatment . In the expansion phase, at least two dos...